Learn more about our Global Affairs work.
Today, AdvaMed, the Medtech Association, released the following statement by President and CEO Scott Whitaker: “On Monday last week, I addressed the MedTech Conference and expressed our profound sadness and…
In light of the ongoing violence in Gaza and Israel following the attack by Hamas, AdvaMed has launched this page to keep members informed of opportunities to support impacted communities…
Join us for a breakdown of the Chinese medical device market, to review the current regulatory requirements and pathways, and address I.P. protection in China for U.S. companies.
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on Secretary of Commerce Gina Raimondo’s trip to China.
Scott Whitaker, President and CEO, of AdvaMed recently had the opportunity to speak with Ambassador Kurt Volker, a distinguished diplomat who served as U.S. Ambassador to NATO and U.S. Special…
Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
AdvaMed and its member companies are working with the U.S. government on medtech donations for humanitarian aid following the devastating earthquakes in southeast Turkey and northern Syria.
AdvaMed, the medtech association, working alongside the Department of Commerce’s International Trade Administration, advocated for and secured the recently implemented transition extensions for certifying medical devices in the European Union…
AdvaMed was privileged to host a delegation from Korea’s Ministry of Food and Drug Safety (MFDS) at our offices for an informative session on the regulation of digital health technology.
The European Union Council approved legislative changes to the Medical Device Regulation (EU MDR), finalizing a 3-4 ½ year extension on implementation of the new rules for certifying medical devices.…